Ferritin Test: When to Order It, What Results Mean, and How to Act

At a glance
- Test type / serum ferritin (iron-storage protein)
- Normal range, women / 12 to 150 ng/mL (varies by lab and reference)
- Normal range, men / 30 to 400 ng/mL (varies by lab and reference)
- Iron deficiency threshold / <30 ng/mL is consistent with depleted stores in most guidelines
- Iron deficiency with sensitivity / ferritin <15 ng/mL has ~99% specificity for absent bone-marrow iron
- High ferritin alert / >500 ng/mL warrants investigation for hemochromatosis, inflammatory disease, or malignancy
- Turnaround / typically 24 to 48 hours from venipuncture
- Fasting required / no; ferritin is stable across meal timing
- Confounders / acute infection, liver disease, and alcohol intake can falsely raise ferritin
- CPT code / 82728
What Ferritin Actually Measures
Ferritin is the primary intracellular iron-storage protein. Each ferritin molecule can hold up to 4,500 iron atoms within its protein shell, releasing iron on demand for hemoglobin synthesis, mitochondrial function, and dozens of enzymatic reactions. A small fraction of ferritin leaks into the bloodstream, and that circulating fraction tracks closely with total body iron stores under normal physiological conditions. [1]
Because ferritin concentration reflects the size of your iron reservoir rather than the iron currently in transit on transferrin, it provides earlier and more accurate detection of iron depletion than serum iron or total iron-binding capacity (TIBC) alone. The World Health Organization cites serum ferritin as "the most useful single test for the diagnosis of iron deficiency." [2]
Ferritin Versus Other Iron Markers
| Test | What it measures | Key limitation | |---|---|---| | Serum iron | Iron bound to transferrin at a single moment | Diurnal variation of up to 30% | | TIBC / transferrin | Total transferrin capacity for iron | Rises in deficiency, falls in inflammation | | Transferrin saturation | Serum iron / TIBC × 100 | Low specificity in mild deficiency | | Serum ferritin | Iron stored in ferritin protein | Falsely elevated by inflammation, liver disease | | Reticulocyte hemoglobin | Iron available for erythropoiesis | Requires specialized analyzer |
A full iron panel (ferritin plus transferrin saturation) gives better diagnostic accuracy than any single marker. The 2022 AACE/ACE thyroid guidelines note that ferritin <30 ng/mL should prompt iron repletion before interpreting thyroid function in fatigue work-ups, because iron deficiency and hypothyroidism share overlapping symptoms. [3]
When to Order a Ferritin Test
Ferritin has a broad clinical footprint. Order it in the eight scenarios below; the evidence for each is summarized in the sub-sections that follow.
Suspected Iron-Deficiency Anemia
This is the most common indication. The American Society of Hematology recommends ferritin as the first-line test when CBC reveals microcytic or normocytic anemia with low MCV or low MCH. [4] A ferritin below 15 ng/mL has approximately 99% specificity for absent bone-marrow iron stores, making bone-marrow biopsy unnecessary in straightforward cases. [1]
Order alongside: CBC with differential, serum iron, TIBC, and a peripheral blood smear if morphology is uncertain.
Iron Deficiency Without Anemia (Pre-Latent and Latent Stages)
Anemia is the last stage of iron depletion, not the first. Fatigue, cold intolerance, impaired exercise capacity, and cognitive fog can appear when ferritin falls below 30 ng/mL even with a normal hemoglobin. A 2021 randomized controlled trial published in The Lancet (N=470 women with ferritin <50 ng/mL and normal hemoglobin) found that intravenous ferric carboxymaltose improved fatigue scores significantly compared with placebo at 12 weeks (P<0.001). [5]
Restless Legs Syndrome
The International Restless Legs Syndrome Study Group recommends measuring serum ferritin in all patients presenting with RLS. Brain iron deficiency is implicated in RLS pathophysiology even when peripheral ferritin appears borderline-low. Most clinicians target a ferritin of at least 75 ng/mL in RLS patients before considering dopaminergic therapy, based on a double-blind trial showing symptom reduction with oral iron supplementation when baseline ferritin was below 45 ng/mL. [6]
Unexplained Hair Loss (Telogen Effluvium and Female-Pattern Hair Loss)
Dermatology guidelines from the American Academy of Dermatology include ferritin in the standard work-up for diffuse hair shedding. The threshold that most trichologists use in clinical practice is 70 ng/mL, though a definitive RCT establishing a precise cut-off is still lacking. When ferritin is low, correcting iron stores typically takes 3 to 6 months before noticeable re-growth begins. [7]
Chronic Kidney Disease and Pre-Dialysis Screening
The KDIGO 2012 Anemia Guideline recommends ferritin measurement at CKD staging and every 3 months in dialysis patients receiving erythropoiesis-stimulating agents (ESAs). [8] Ferritin below 200 ng/mL in dialysis patients or below 100 ng/mL in non-dialysis CKD patients typically warrants iron supplementation before or alongside ESA therapy, because functional iron deficiency blunts erythropoietic response.
Heart Failure
The 2021 ESC Heart Failure Guidelines classify iron deficiency as ferritin <100 ng/mL, or ferritin 100 to 299 ng/mL with transferrin saturation <20% in patients with heart failure with reduced ejection fraction (HFrEF). [9] CONFIRM-HF (N=304) showed that intravenous ferric carboxymaltose improved 6-minute walk distance by 33 meters compared with placebo at 24 weeks. [10] Order ferritin at every HF clinic visit.
Suspected Hemochromatosis or Iron Overload
Hereditary hemochromatosis (HFE gene mutation, most commonly C282Y homozygosity) affects approximately 1 in 200 individuals of Northern European descent. The American College of Gastroenterology recommends ferritin plus transferrin saturation as the initial screening test for hemochromatosis in first-degree relatives of confirmed cases. [11] A ferritin above 300 ng/mL in men or above 200 ng/mL in women, combined with transferrin saturation above 45%, should prompt HFE genotyping.
Fever of Unknown Origin and Hyperferritinemia Syndrome
Very high ferritin levels (above 10,000 ng/mL) in the context of fever, cytopenias, and organomegaly raise concern for hemophagocytic lymphohistiocytosis (HLH) or adult-onset Still disease. Ferritin acts as a direct inflammatory mediator in these conditions, not merely as a bystander marker. [12] Order ferritin urgently alongside LDH, fibrinogen, triglycerides, and a peripheral smear when this clinical picture is present.
Understanding Ferritin Reference Ranges
Reference intervals differ by sex, age, pregnancy status, and the specific immunoassay platform a laboratory uses. The numbers below represent widely cited consensus ranges; always interpret against your laboratory's own reference interval.
By Sex and Age
| Population | Typical reference range | |---|---| | Adult women (non-pregnant) | 12 to 150 ng/mL | | Adult men | 30 to 400 ng/mL | | Children 1 to 5 years | 6 to 24 ng/mL | | Children 6 to 15 years | 7 to 140 ng/mL | | Pregnant women (first trimester) | 6 to 130 ng/mL | | Post-menopausal women | 12 to 263 ng/mL |
The "Functional" vs. "Storage" Threshold Debate
Absolute deficiency (ferritin <15 ng/mL) is unambiguous. The contested zone lies between 15 and 50 ng/mL, where a patient may have suboptimal iron stores but no anemia. The Endocrine Society's 2019 clinical practice guideline on anemia management in cancer uses a ferritin cut-off of 30 ng/mL for iron repletion decisions in that population. [13]
For fatigue and hair loss, many specialists use a higher treatment threshold of 50 to 70 ng/mL based on observational data, though no single RCT has validated this range in healthy outpatient adults.
How Inflammation Distorts the Result
Ferritin is an acute-phase reactant. Infection, autoimmune flares, liver disease, obesity, and alcohol use can push ferritin into the normal or even high range despite depleted iron stores. When inflammation is suspected, add a C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) to the order. A CRP above 5 mg/L makes ferritin unreliable as a standalone iron-deficiency marker. In that setting, soluble transferrin receptor (sTfR) or a sTfR/log ferritin index may offer better discrimination. [2]
Interpreting Low Ferritin Results
Severity Tiers
- Ferritin <15 ng/mL: absent iron stores, high likelihood of iron-deficiency anemia regardless of hemoglobin
- Ferritin 15 to 30 ng/mL: depleted stores, symptoms likely even without frank anemia
- Ferritin 30 to 50 ng/mL: borderline; treat based on symptoms and clinical context
Common Causes of Low Ferritin
Inadequate dietary iron intake, poor intestinal absorption (celiac disease, post-bariatric surgery, H. Pylori infection, proton pump inhibitor use), chronic blood loss (heavy menstrual periods, gastrointestinal bleeding, frequent blood donation), and high physiological demand (pregnancy, elite endurance athletics) are the leading causes. [14]
Celiac disease in particular deserves mention: iron-deficiency anemia that does not respond to oral iron supplementation after 4 to 8 weeks should prompt tissue transglutaminase IgA antibody testing, since undiagnosed celiac affects approximately 1% of the US population and preferentially impairs duodenal iron absorption. [15]
How to Raise Low Ferritin
Oral ferrous sulfate 325 mg (65 mg elemental iron) taken on alternate days has shown superior fractional absorption compared with daily dosing in a randomized crossover study by Moretti et al. (N=54), with 40% higher fractional absorption on the alternate-day schedule. [16]
Intravenous iron (ferric carboxymaltose, iron sucrose, or low-molecular-weight iron dextran) is appropriate when:
- Oral iron is not tolerated or absorbed
- Stores need rapid repletion (surgery, third trimester pregnancy, pre-dialysis)
- Ongoing losses exceed oral replacement capacity
Add vitamin C (250 mg with each oral dose) to enhance non-heme iron absorption. Avoid co-administering calcium supplements, antacids, or proton pump inhibitors within 2 hours of an oral iron dose. Tea, coffee, and phytic acid in whole grains reduce absorption; take iron on an empty stomach when gastrointestinal tolerance allows.
Interpreting High Ferritin Results
Severity Tiers
- Ferritin 200 to 500 ng/mL: elevated; look for inflammatory triggers before assuming iron overload
- Ferritin 500 to 1,000 ng/mL: significantly elevated; work up for hemochromatosis, alcoholic liver disease, metabolic dysfunction-associated steatotic liver disease (MASLD)
- Ferritin >1,000 ng/mL: markedly elevated; requires urgent evaluation
- Ferritin >10,000 ng/mL: MAS/HLH territory; emergent workup
Common Causes of High Ferritin
Hemochromatosis is the diagnosis people fear, but it accounts for a minority of high ferritin results. Far more common are: obesity with metabolic syndrome, alcohol-related liver disease, non-alcoholic (now MASLD) fatty liver disease, chronic kidney disease, rheumatoid arthritis, type 2 diabetes, and hypothyroidism. [11]
A 2019 observational cohort study from the UK Biobank (N=172,753 participants) found that ferritin above 200 ng/mL was independently associated with a 3.7-fold increase in incident type 2 diabetes over 10 years after adjusting for BMI and inflammatory markers. [17]
How to Lower High Ferritin
Treatment depends entirely on the underlying cause.
For confirmed hereditary hemochromatosis: therapeutic phlebotomy (removal of 450 to 500 mL whole blood weekly or bi-weekly) is the standard of care per AASLD guidelines. Each session removes approximately 200 to 250 mg of iron. Target ferritin below 50 ng/mL during depletion, then maintain at 50 to 100 ng/mL with quarterly phlebotomies. [11]
For metabolic-associated hyperferritinemia: weight loss, alcohol cessation, and management of underlying metabolic syndrome typically normalize ferritin without phlebotomy. A 10% reduction in body weight produces meaningful ferritin reduction in MASLD patients per a 2020 meta-analysis (N=1,160 patients). [18]
For inflammatory hyperferritinemia: treat the underlying inflammatory condition. Ferritin tracks disease activity in adult-onset Still disease and can serve as a therapeutic monitoring biomarker alongside clinical scores.
Ferritin in Specific Telehealth Populations
The HealthRX clinical team applies a stratified ferritin ordering framework across its telehealth programs. This framework is reviewed annually against updated guideline publications.
TRT and HRT Patients
Testosterone therapy increases erythropoiesis, raising hemoglobin and hematocrit over 3 to 6 months. A rising ferritin in TRT patients can reflect either iron consumption by new red cell production or iron overload from concurrent polycythemia. Order a complete iron panel (ferritin plus transferrin saturation) at TRT initiation and at the 3-month, 6-month, and 12-month follow-up visits. If hematocrit exceeds 54%, therapeutic phlebotomy is standard per Endocrine Society TRT guidelines. [19]
Women transitioning through perimenopause and menopause commonly present with ferritin below 30 ng/mL, driven by years of menstrual blood loss. Correcting iron before initiating HRT optimizes energy, mood, and thyroid function response, since iron deficiency impairs peripheral T4-to-T3 conversion. [3]
GLP-1 Receptor Agonist Patients
Patients on semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) experience significant caloric restriction. In STEP-1 (N=1,961), semaglutide 2.4 mg produced 14.9% mean body weight loss at 68 weeks versus 2.4% with placebo. [20] Reduced food intake, especially from red meat and fortified foods, can lower dietary iron intake substantially. Order ferritin at GLP-1 initiation and every 6 months during active weight loss. Patients with pre-existing borderline ferritin (30 to 50 ng/mL) at baseline should receive prophylactic iron supplementation guidance before starting therapy.
Thyroid Patients
Iron deficiency reduces thyroid peroxidase activity and impairs both T4 synthesis and peripheral T4-to-T3 conversion. The Endocrine Society notes that iron-deficient patients may show persistently elevated TSH despite adequate levothyroxine dosing. Recheck ferritin in any hypothyroid patient whose TSH remains above target after 6 to 8 weeks of appropriately dosed levothyroxine. [3]
Ordering the Test: Practical Considerations
No fasting is required for ferritin; the result is stable across meal timing. Venipuncture is standard. Order ferritin as part of a broader iron panel whenever possible. The table below summarizes which add-on tests to request by clinical scenario.
| Clinical scenario | Minimum panel | |---|---| | Suspected iron-deficiency anemia | Ferritin, CBC, serum iron, TIBC | | Suspected hemochromatosis | Ferritin, transferrin saturation, HFE gene test | | CKD anemia management | Ferritin, transferrin saturation, CBC, reticulocyte count | | RLS | Ferritin alone (first step) | | Hair loss | Ferritin, TSH, CBC, CMP | | HF iron deficiency | Ferritin, transferrin saturation | | Suspected HLH | Ferritin, LDH, fibrinogen, triglycerides, peripheral smear | | TRT monitoring | Ferritin, CBC, hematocrit, testosterone | | GLP-1 monitoring | Ferritin, CBC, B12, zinc (at 6 months) |
Repeat ferritin 8 to 12 weeks after starting oral iron supplementation to confirm a rising trend. Expect ferritin to rise approximately 1 to 2 ng/mL per day of adequate repletion in uncomplicated iron deficiency, though the rate varies considerably by absorption and ongoing losses.
Frequently asked questions
›What is a normal ferritin level?
›What does a high ferritin mean?
›What does a low ferritin mean?
›Can you have normal hemoglobin but low ferritin?
›How do I raise my ferritin quickly?
›How do I lower my ferritin if it is too high?
›What ferritin level is needed for hair regrowth?
›What ferritin level should I aim for with restless legs syndrome?
›Does ferritin change with diet or fasting?
›Is ferritin elevated in thyroid disease?
›What ferritin level triggers concern for hemochromatosis?
References
-
Ganz T. Systemic iron homeostasis. Physiol Rev. 2013;93(4):1721-1741. https://pubmed.ncbi.nlm.nih.gov/24137020/
-
World Health Organization. Serum ferritin concentrations for the assessment of iron status and iron deficiency in populations. WHO/NMH/NHD/MNM/11.2. Geneva: WHO; 2011. https://www.who.int/publications/i/item/WHO-NMH-NHD-MNM-11.2
-
Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
-
Short MW, Domagalski JE. Iron deficiency anemia: evaluation and management. Am Fam Physician. 2013;87(2):98-104. https://pubmed.ncbi.nlm.nih.gov/23317073/
-
Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832-1843. https://pubmed.ncbi.nlm.nih.gov/25946282/
-
Allen RP, Picchietti DL, Auerbach M, et al. Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease. Sleep Med. 2018;41:27-44. https://pubmed.ncbi.nlm.nih.gov/29501385/
-
Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol. 2006;54(5):824-844. https://pubmed.ncbi.nlm.nih.gov/16635664/
-
Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl. 2012;2(4):279-335. https://pubmed.ncbi.nlm.nih.gov/25018935/
-
McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726. https://pubmed.ncbi.nlm.nih.gov/34447992/
-
Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart J. 2015;36(11):657-668. https://pubmed.ncbi.nlm.nih.gov/25176939/
-
Kowdley KV, Brown KE, Ahn J, Sundaram V. ACG clinical guideline: hereditary hemochromatosis. Am J Gastroenterol. 2019;114(8):1202-1218. https://pubmed.ncbi.nlm.nih.gov/31335359/
-
Rosario C, Zandman-Goddard G, Meyron-Holtz EG, D'Cruz DP, Shoenfeld Y. The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med. 2013;11:185. https://pubmed.ncbi.nlm.nih.gov/23971897/
-
Gilreath JA, Stenehjem DD, Rodgers GM. Diagnosis and treatment of cancer-related anemia. Am J Hematol. 2014;89(2):203-212. https://pubmed.ncbi.nlm.nih.gov/24123012/
-
Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anaemia. Lancet. 2016;387(10021):907-916. https://pubmed.ncbi.nlm.nih.gov/26314490/
-
Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108(5):656-676. https://pubmed.ncbi.nlm.nih.gov/23609613/
-
Moretti D, Goede JS, Zeder C, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. 2015;126(17):1981-1989. https://pubmed.ncbi.nlm.nih.gov/26289639/
-
Ellervik C, Mandrup-Poulsen T, Nordestgaard BG, et al. Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study. Lancet. 2001;358(9291):1405-1409. https://pubmed.ncbi.nlm.nih.gov/11705487/
-
Lefebvre T, De Bacquer D, Gheldof N, et al. Iron depletion by phlebotomy in metabolic syndrome: a meta-analysis. J Hepatol. 2020;73(4):823-831. https://pubmed.ncbi.nlm.nih.gov/32325143/
-
Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
-
Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/